WO2019025803A3 - An antimicrobial composition - Google Patents

An antimicrobial composition

Info

Publication number
WO2019025803A3
WO2019025803A3 PCT/GB2018/052208 GB2018052208W WO2019025803A3 WO 2019025803 A3 WO2019025803 A3 WO 2019025803A3 GB 2018052208 W GB2018052208 W GB 2018052208W WO 2019025803 A3 WO2019025803 A3 WO 2019025803A3
Authority
WO
WIPO (PCT)
Prior art keywords
antimicrobial composition
ajoene
honey
skin
treating
Prior art date
Application number
PCT/GB2018/052208
Other languages
French (fr)
Other versions
WO2019025803A2 (en
Inventor
Carl Jorg Michael GRAZ
Gareth James Street Evans
Danielle Michaela WILLIAMS
Original Assignee
Neem Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neem Biotech Ltd filed Critical Neem Biotech Ltd
Publication of WO2019025803A2 publication Critical patent/WO2019025803A2/en
Publication of WO2019025803A3 publication Critical patent/WO2019025803A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/105—Persulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention provides an antimicrobial composition comprising honey and ajoene for use in treating or preventing a skin and/or wound infection in a subject. Methods for treating or preventing a skin and/or wound infection, comprising administering a therapeutically or prophylactically effective amount of an antimicrobial composition comprising honey and ajoene to a subject in need thereof are also described.
PCT/GB2018/052208 2017-08-03 2018-08-02 An antimicrobial composition WO2019025803A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1712501.4 2017-08-03
GBGB1712501.4A GB201712501D0 (en) 2017-08-03 2017-08-03 An antimicrobial composition

Publications (2)

Publication Number Publication Date
WO2019025803A2 WO2019025803A2 (en) 2019-02-07
WO2019025803A3 true WO2019025803A3 (en) 2019-05-02

Family

ID=59894943

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2018/052208 WO2019025803A2 (en) 2017-08-03 2018-08-02 An antimicrobial composition

Country Status (2)

Country Link
GB (1) GB201712501D0 (en)
WO (1) WO2019025803A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113143911A (en) * 2021-04-26 2021-07-23 吉林大学 Application of procyanidine in preparation of Listeria monocytogenes sortase inhibitor

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2925856A1 (en) * 2007-12-28 2009-07-03 Patrick Mamou Composition obtained by process of combining different natural elements and optimizing their properties against growth of herpes labialis and/or solar effects, useful e.g. to treat burns, skin diseases, eye infections and skin irritations
WO2015074159A1 (en) * 2013-11-25 2015-05-28 Dermal Devices Inc. Composition, system and method for treating skin
US20150150930A1 (en) * 2013-12-02 2015-06-04 Laïd BOUKRAA Aro-honey starch gel for wounds, burns and skin care
WO2016102931A1 (en) * 2014-12-23 2016-06-30 Neem Biotech Ltd An antimicrobial composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2925856A1 (en) * 2007-12-28 2009-07-03 Patrick Mamou Composition obtained by process of combining different natural elements and optimizing their properties against growth of herpes labialis and/or solar effects, useful e.g. to treat burns, skin diseases, eye infections and skin irritations
WO2015074159A1 (en) * 2013-11-25 2015-05-28 Dermal Devices Inc. Composition, system and method for treating skin
US20150150930A1 (en) * 2013-12-02 2015-06-04 Laïd BOUKRAA Aro-honey starch gel for wounds, burns and skin care
WO2016102931A1 (en) * 2014-12-23 2016-06-30 Neem Biotech Ltd An antimicrobial composition

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANNABELLE WHATMOUGH ET AL: "P17 Identification of a novel synergistic combination of natural extracts for infection control in diabetic ulcers", BIOCHEMICAL PHARMACOLOGY, vol. 139, 1 September 2017 (2017-09-01), US, pages 130, XP055567285, ISSN: 0006-2952, DOI: 10.1016/j.bcp.2017.06.018 *
HARTMAN-ADAMS H ET AL: "Impetigo: Diagnosis and treatment", AMERICAN FAMILY PHYSICIAN 20140815, vol. 90, no. 4, 15 August 2014 (2014-08-15), pages 229 - 235, XP055567630, ISSN: 0002-838X *
NADALO D ET AL: "What is the best way to treat tinea cruris?", JOURNAL OF FAMILY PRAC, NEW YORK, NY, US, vol. 55, no. 3, 1 January 2006 (2006-01-01), pages 256 - 258, XP009116119, ISSN: 0094-3509 *
WESSAM A. SARHAN ET AL: "Honey/Chitosan Nanofiber Wound Dressing Enriched with Allium sativum and Cleome droserifolia : Enhanced Antimicrobial and Wound Healing Activity", ACS APPLIED MATERIALS & INTERFACES, vol. 8, no. 10, 16 March 2016 (2016-03-16), US, pages 6379 - 6390, XP055335814, ISSN: 1944-8244, DOI: 10.1021/acsami.6b00739 *

Also Published As

Publication number Publication date
GB201712501D0 (en) 2017-09-20
WO2019025803A2 (en) 2019-02-07

Similar Documents

Publication Publication Date Title
PH12017502297A1 (en) Antibacterial compounds
NZ713621A (en) Compounds and methods of treating infections
EP3862009A4 (en) Composition for skin regeneration and wound healing, comprising induced exosomes
BR112016030541A2 (en) Methods For Treating Yeast Infections
WO2016142445A3 (en) Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
BR112018015367A2 (en) nanofiber oromucosal carriers for therapeutic treatment
TW201613578A (en) Pharmaceutical combinations
MX2022003037A (en) Antibacterial compounds.
EA201692481A1 (en) COMBINATION CONTAINING GLUCOCORTICOID AND EDO-S101
MX2019001633A (en) Silk-derived protein for treating inflammation.
WO2017075188A3 (en) Methods of using anti-alpha toxin antibody
WO2019157495A3 (en) Methods for preventing and/or treating bone loss conditions by modulating irisin
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
WO2014152437A3 (en) Methods of use for an antimicrobial peptide
BR112019004791A2 (en) multiple sclerosis treatment with chs-131
WO2015126930A3 (en) Booster drug therapy for mycobacterium infections
EP3821884A4 (en) Use of compound in drug for preventing, treating, or alleviating pain
MX2020005056A (en) Emulsions for the topical treatment of dermal infections and mucosal infections.
PH12018501624A1 (en) A composition comprising pic for treatment of cancer
WO2019025803A3 (en) An antimicrobial composition
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
EP3789019A4 (en) Composition for prevention or treatment of skin infection
EA201692493A8 (en) ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS WITH THE ABILITY TO INHIBIT MULTIPLE DOSE SUSTAINABILITY
EP3744347A4 (en) Composition for skin diseases treatment use
EP3668526A4 (en) Compositions for treating skin and mucous membrane infections

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18833489

Country of ref document: EP

Kind code of ref document: A2